phone: +46 (0)42 20 71 10   |   e-mail: info@caprascience.com

  • ANTIBODY PRODUCTION
    • POLYCLONAL ANTIBODY PRODUCTION >
      • POLYCLONAL ANTIBODY PRODUCTION / GOAT
      • POLYCLONAL ANTIBODY PRODUCTION / RABBIT
      • POLYCLONAL ANTIBODY PRODUCTION / HEN
    • MONOCLONAL ANTIBODY PRODUCTION >
      • HYBRIDOMA GENERATION
      • PRODUCTION FROM EXISTING HYBRIDOMA
      • CLONING & EXPRESSION OF ANTIBODY
    • PEPTIDE-SPECIFIC ANTIBODY PRODUCTION >
      • PEPTIDE DESIGN
      • PEPTIDE SYNTESIS & CONJUGATION
      • PHOSPHO-SPECIFIC ANTIBODIES
    • ANTIGEN/PROTEIN PRODUCTION
    • NORMAL SERUM
    • PITX2 ANTIBODIES
  • ANTIBODY SERVICES
    • ANTIBODY PURIFICATIONS
    • ANTIBODY CONJUGATIONS
    • CHARACTERIZATION >
      • ANTIBODY TARGET VALIDATION / CROSS-REACTIVITY STUDIES >
        • WESTERN BLOT ANALYSIS SERVICE
        • ELISA DEVELOPMENT
        • IMMUNOHISTOCHEMISTRY SERVICES
      • AFFINITY MEASUREMENTS OF ANTIBODIES
      • EPITOPE-MAPPING
    • BIOASSAY / DIAGNOSTIC ASSAY DEVELOPMENT >
      • ASSAY DEVELOPMENT
      • DIAGNOSTIC ANTIBODY ASSAY DEVELOPMENT
  • ANIMAL CARE
    • CAPRA SCIENCE IMMUNIZATION PROGRAM™
    • CAPRA CARE™
    • ORGANIC FARM
  • CONTACT
  • ABOUT US
    • VISION
    • OUR CONCEPT
    • OUR TEAM
    • TRACK RECORD & CLIENTS
    • CONSULTATION
    • CAREER
  • NEWS

Humanized antibody drug used in the fight against Ebola 

8/15/2014

0 Comments

 
PictureEbola virus particle
In an attempt to fight the outbreak of ebola in West Africa, the FDA has approved a limited use of a new drug composed of three humanized monoclonal antibodies.  The drug, which is being developed by Mapp Biopharmaceutical (1), has not yet reached the clinic but the importance of the drug for stopping the Ebola outbreak in West Africa has forced the FDA to grant it viable for limited use before all tests have been carried out.

The number of FDA approved humanized antibodies for therapeutic treatments are now in the thirties, and hundreds of antibody therapies are undergoing clinical trials. Capra Science Antibodies AB is a trusted partner in the development of humanized antibodies for health care.  The expertise of the Capra Science team includes the range of steps including monoclonal antibody generation, humanization process, antibody production for R&D and pre-clinical evaluation.

(1)ZMapp was developed as a result of the collaboration between Mapp Biopharmaceutical, LeadBio, Defyrus and US government and Canadian Public Health Agency of Canada. 


0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Picture
    Capra Science is your Antibody Expert and your No. 1 choice for Antibody Services. 


    Follow our Organic Farm on Instagram ››


    Categories

    All
    Awards
    Field News
    Production
    Services
    Special Offers

    RSS Feed

Our farm location
Our certified EU organic farm is located in Sweden.  We are proud to say that Swedish authorities have some of the strictest regulations worldwide for animal keeping, ethics and the environment. Learn more ››
Capra Science location in Sweden, Europe
Contact us
phone: +46 (0)42 20 71 10  
e-mail: info@caprascience.com


Our Terms & Conditions
© Copyright 2014 Capra Science Antibodies AB. All rights reserved.

BACK TO TOP

© Capra Science | All Rights Reserved